| Item Type | Name |
|
Concept
|
Coronary Artery Disease
|
|
Academic Article
|
Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease.
|
|
Academic Article
|
Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE)-rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease.
|
|
Academic Article
|
Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.
|
|
Academic Article
|
Comparative effects of lipid-lowering therapies.
|
|
Academic Article
|
Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.
|
|
Academic Article
|
How low to target LDL?
|
|
Academic Article
|
Statin safety: an assessment using an administrative claims database.
|
|
Academic Article
|
High-density lipoprotein metabolism: potential therapeutic targets.
|
|
Academic Article
|
Reducing the residual risk of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor therapy with combination therapy.
|
|
Academic Article
|
The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
|
|
Academic Article
|
Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
|
|
Academic Article
|
Effect of ACAT inhibition on the progression of coronary atherosclerosis.
|
|
Academic Article
|
Novel targets that affect high-density lipoprotein metabolism: the next frontier.
|
|
Academic Article
|
Pioglitazone versus glimepiride on coronary artery calcium progression in patients with type 2 diabetes mellitus: a secondary end point of the CHICAGO study.
|
|
Academic Article
|
Niacin therapy: an evolving paradigm for the management of mixed dyslipidemia and low high-density lipoprotein cholesterol. Introduction.
|
|
Academic Article
|
Atherosclerosis surrogate imaging trials come of age: for better or for worse?
|
|
Academic Article
|
Introduction. U.S. incidence of coronary artery disease.
|
|
Academic Article
|
Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction.
|
|
Academic Article
|
Focus on HDL as a therapeutic target for CAD risk reduction.
|
|
Academic Article
|
Novel developments in omega-3 fatty acid-based strategies.
|
|
Academic Article
|
Cardiovascular risk factors in a patient with diabetes mellitus and coronary artery disease: therapeutic approaches to improve outcomes: perspectives of a preventive cardiologist.
|
|
Academic Article
|
Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region.
|
|
Academic Article
|
Apolipoprotein A-I therapy promise, challenges, and disappointment.
|
|
Academic Article
|
Niacin: a powerful adjunct to other lipid-lowering drugs in reducing plaque progression and acute coronary events.
|
|
Academic Article
|
Emerging therapeutic strategies for the management of dyslipidemia in patients with the metabolic syndrome.
|
|
Academic Article
|
Relationship of traditional and nontraditional cardiovascular risk factors to coronary artery calcium in type 2 diabetes.
|
|
Academic Article
|
The role of cardiologists in the management of patients with diabetes is evolving owing to the close relationship between diabetes and CAD. Introduction.
|
|
Academic Article
|
Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial.
|
|
Academic Article
|
Myocardial viability in asynergic regions subtended by occluded coronary arteries: relation to the status of collateral flow in patients with chronic coronary artery disease.
|
|
Academic Article
|
Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis.
|
|
Academic Article
|
Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians: the Strong Heart Study.
|
|
Academic Article
|
Collaborative multidisciplinary workshop report: the role of epidemiology studies in determining a possible relationship between Chlamydia pneumoniae infection and atherothrombotic diseases.
|
|
Academic Article
|
Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance.
|
|
Academic Article
|
Statistical genetic analysis of serological measures of common, chronic infections in Alaska Native participants in the GOCADAN study.
|
|
Academic Article
|
The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
|
|
Academic Article
|
The Role of Genetics in Cardiovascular Risk Reduction: Findings From a Single Lipid Clinic and Review of the Literature.
|
|
Academic Article
|
The Battle of the HDL Subfractions.
|
|
Academic Article
|
Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group.
|